Clinical Performance Evaluation of AMH Assay

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

NCT00362479 ·Status: COMPLETED ·Phase: PHASE3

Study of Safety and Efficacy of an Oral Contraceptive

NCT00391807 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

NCT00380887 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of Pregnancy

NCT00996580 ·Status: COMPLETED ·Phase: PHASE3

Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contraceptive

NCT00196326 ·Status: COMPLETED ·Phase: PHASE3

Assessing the Effect of Multiple Doses of Zibotentan on the Pharmacokinetics of Single Doses of Combined Oral Contraceptives in Healthy Female Participants of Non-childbearing Potential.

NCT05505162 ·Status: COMPLETED ·Phase: PHASE1

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

NCT05139121 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women

NCT01861886 ·Status: COMPLETED ·Phase: NA

Study to Investigate Efficacy and Safety of a New Oral Contraceptive

NCT00185289 ·Status: COMPLETED ·Phase: PHASE3

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)

NCT00511355 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Compliance With the Oral Contraceptive SH T00186D in a Flexible Extended Regimen Supported by a Dispenser With a Reminder Function

NCT01257984 ·Status: COMPLETED ·Phase: PHASE3

Clearblue® Advanced Ovulation Test User Study

NCT03122951 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

NCT00206583 ·Status: COMPLETED ·Phase: PHASE3

Effects on Bone Mineral Density (BMD) of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG/EE (292005)(P05765)(COMPLETED)

NCT00511342 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation

NCT00630435 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy

NCT01178125 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

NCT00307632 ·Status: COMPLETED ·Phase: PHASE4

Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females

NCT02792517 ·Status: COMPLETED ·Phase: PHASE1

A Study of Oral Contraception Under Simulated OTC Conditions

NCT03559010 ·Status: TERMINATED ·Phase: PHASE3

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

NCT00318318 ·Status: COMPLETED ·Phase: PHASE1

Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.

NCT00381251 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

NCT01709318 ·Status: COMPLETED ·Phase: PHASE2

Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)

NCT01650168 ·Status: COMPLETED

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

NCT01140217 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

NCT02080468 ·Status: COMPLETED ·Phase: PHASE1